Gland Pharma Ltd.

₹1417.8

Gland Pharma Ltd.

₹1417.8

₹1417.8

4.9 (0.35%) - 30 Apr 2025 12:35 PM

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹23,278 Cr.
52 Week - High/Low ₹2,221/1,278
P/E Ratio 20.76
P/B Ratio 2.59
Enterprise Value ₹21,811 Cr.
ROE % 12.31
RSI Value 47.24
EMA 50 1521.7
EMA 200 1660.13
Market Cap. ₹23,278 Cr.
52 Week - High/Low ₹2,221/1,278
P/E Ratio 33.04
P/B Ratio 2.67
Enterprise Value ₹21,928 Cr.
ROE % 9.26
RSI Value 47.24
EMA 50 1521.7
EMA 200 1660.13

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.